In an era where chronic inflammatory diseases are taking centre stage in healthcare debates, the biologics segment is ...

One of the keys to a comfortable retirement is finding a steady and reliable stream of passive income. But Social Security ...

AbbVie on Wednesday said the replicate Phase 3 studies met their co-primary endpoints of reduction in de-pigmentation over the entire body and the face in adults and adolescents with non-segmental ...

Bristol Myers Squibb Co. raised its revenue outlook for the year after newer medicines outperformed expectations, easing ...

Today, AbbVie has announced that Canada's Drug Agency (CDA-AMC), formerly CADTH, has recommended that ELAHERE® (mirvetuximab soravtansine for injection), an antibody-drug conjugate (ADC), be ...

Bicycle Therapeutics plc (NASDAQ: BCYC), a pharmaceutical company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (Bicycle®) technology, today ...

Market OverviewThe Global Anti-Aging Market is projected to grow at a CAGR of approximately 5–6% by 2029. The market’s growth is driven by a rising aging population, rapid technological advancements ...

The poster will be available on November 7, 2025 under the “Our Approach—Presentations & Publications” section of the Xilio Therapeutics website at www.xiliotx.com.

Xilio Therapeutics, Inc. (Nasdaq: XLO), a clinical-stage biotechnology company discovering and developing tumor-activated ...

Piramal Pharma Solutions has joined forces with IntoCell to broaden its bioconjugates offering and support innovation in the ...

Allergan Aesthetics, an AbbVie company , today announced the seventh annual BOTOX® Cosmetic Day will take place on Wednesday, ...

The FDA is planning to speed approvals of highly similar copies of expensive biologic drugs, the latest effort in President ...